Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial
Titel:
Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial
Auteur:
Papp, Kim Thaçi, Diamant Marcoux, Danielle Weibel, Lisa Philipp, Sandra Ghislain, Pierre-Dominique Landells, Ian Hoeger, Peter Kotkin, Carol Unnebrink, Kristina Seyger, Marieke Williams, David